Heart surgery drug trial aims to shield kidneys from harm
NCT ID NCT04633889
Summary
This study is testing whether a drug called deferoxamine can prevent kidney injury in patients having heart surgery with a heart-lung bypass machine. The trial involves 320 adults at higher risk for this complication, who will receive either the drug or a placebo before and during their operation. Researchers believe iron released during surgery may damage the kidneys, and this drug aims to bind that iron to protect them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.